E. Ohman J or Asset Management AB Has $2.71 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

E. Ohman J or Asset Management AB raised its position in HCA Healthcare, Inc. (NYSE:HCA) by 14.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 9,030 shares of the company’s stock after buying an additional 1,130 shares during the period. E. Ohman J or Asset Management AB’s holdings in HCA Healthcare were worth $2,710,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. FMR LLC grew its position in shares of HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after buying an additional 2,397,883 shares during the period. Meritage Group LP bought a new stake in shares of HCA Healthcare during the 3rd quarter valued at $150,548,000. Canoe Financial LP grew its stake in shares of HCA Healthcare by 226,952.9% during the fourth quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock worth $69,513,000 after purchasing an additional 231,492 shares during the period. Holocene Advisors LP lifted its stake in HCA Healthcare by 210.6% in the third quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock valued at $124,691,000 after buying an additional 208,015 shares during the period. Finally, Nordea Investment Management AB increased its stake in shares of HCA Healthcare by 29.7% in the 4th quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock valued at $253,020,000 after acquiring an additional 193,075 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have commented on HCA. Morgan Stanley lowered their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Truist Financial reduced their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Oppenheimer raised their price target on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. Bank of America dropped their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Finally, Royal Bank of Canada lowered their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Trading Up 0.3 %

NYSE HCA opened at $335.31 on Wednesday. The company has a market cap of $84.93 billion, a PE ratio of 15.26, a PEG ratio of 1.13 and a beta of 1.64. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock has a 50 day moving average of $313.52 and a 200-day moving average of $353.59. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the company earned $5.90 earnings per share. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.89 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is 12.02%.

Insiders Place Their Bets

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This represents a 29.76 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.